Cell Isolation Market

The global cell isolation market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.2 billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Various elements such as increasing government funding for cell-based research and the increasing number of patients suffering from cancer & infectious diseases, and the technological advancements, are driving the market growth.

Attractive Opportunities in the Cell Isolation Market

To know about the assumptions considered for the study, Request for Free Sample Report

Cell Isolation Market Dynamics

DRIVER: Increased government funding for cell-based research

For the development of cell-based treatments, cell isolation is the critical step. Cell-based research is important in several applications, hence various government bodies across the world have funded for such research activities. For instance, in May 2021, the National Institutes of Health (NIH) announced the award of USD 30.0 million in grants to support research aimed at developing new tools and technologies for studying cells. The funding was awarded to multiple institutions across the United States, including Harvard University, the University of California San Francisco, and the University of Texas Southwestern Medical Center. Moreover, under the Government’s Medical Research Future Fund (MRFF), the Stem Cell Therapies Mission is investing USD 150.0 million over 10 years. This investment will be utilized in stem cell research, which will eventually improve healthcare outcomes. This type of funding will boost cell-based research globally, leading to an increase in the demand for cell isolation products and ultimately boosting the market.

RESTRAINT: Safety & ethical issues to hamper the market growth

The process of embryonic stem cells isolation involves the destruction of the embryo from which the cells are derived. This raises ethical concerns about the destruction of human life, as the embryo is considered by some to be a potential human being. Embryonic stem cells have the ability to form teratomas, which are tumors that contain cells from all three germ layers. If embryonic stem cells are transplanted into a patient without proper screening, they can potentially form tumors and cause harm. Thus, these factors can potentially hamper the market growth to a certain extent.

OPPORTUNITY: Growth opportunities in emerging markets

Emerging markets such as China, India, and Brazil are experiencing rapid growth in their biopharmaceutical industries. This is driven by factors such as increasing healthcare spending, a growing aging population, and a rise in chronic diseases. The increasing demand for biopharmaceuticals in these markets is driving the need for cell isolation technologies to develop and manufacture these products. Moreover, emerging markets are investing in the development and adoption of advanced technologies such as microfluidics, magnetic cell separation, and flow cytometry. This is improving the efficiency and accuracy of cell isolation processes, and making these technologies more accessible and affordable in these markets. Also, there is a growing trend of research and development activities in emerging markets. Governments and private institutions in these regions are investing in research to develop new therapies and treatments for chronic diseases. Cell isolation is a critical step in the development of these therapies, and thus, the growth of research activities in these markets is driving the growth of the market.

CHALLENGE: Difficulties to develop cell therapies

The development of cell therapies is a major challenge for the market, as it requires the isolation and manipulation of specific cell types that can be used for therapeutic purposes. Different cell types have different characteristics and functions, which makes it difficult to isolate and purify specific cell populations. This can result in a heterogeneous population of cells, which can reduce the effectiveness of the therapy. Isolated cells need to be viable and functional in order to be used in therapies. However, the isolation process can damage cells, which can reduce their viability and functionality. The quality of isolated cells needs to be carefully controlled in order to ensure their safety and effectiveness. This can be challenging, as cells can be affected by a range of environmental factors, such as temperature, pH, and oxygen levels. Overall, these obstacles to the development of cell therapies are significant challenges for the market.

Consumables segment dominated the cell isolation market in 2022.

Based on product, the market is broadly segmented into consumables and instruments. In 2022, consumables accounted for the dominant share of the market. This segment's large share can be attributed to factors such as the repetitive use of consumables in the cell isolation. Furthermore, the increasing number of regulatory approvals of new consumables is likely to upsurge the growth of the segment.

The biomolecule isolation segment of cell isolation market is expected to grow at the highest CAGR during the forecast period.

Based on application, the market is segmented into biomolecule isolation, stem cell research, cancer research, in vitro diagnostics, and tissue regeneration & regenerative medicine, and other applications. The biomolecule isolation segment is expected to register the highest CAGR during the forecast period. Launch of advanced and new products is one of the factors driving the market growth.

To know about the assumptions considered for the study, download the pdf brochure

North America dominated cell isolation market in 2022.

Geographically, the market is divided geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the greatest market share for cell isolation in 2022, followed by Europe and the Asia-Pacific region. A number of variables, including technical development, expansion of the biotechnology and pharmaceutical industries, and rising incidence of infectious and chronic diseases, account for the major share of the American market.

Key players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).

Cell Isolation Market Report Scope:

This report categorizes the cell isolation market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Consumables
  • Reagents, Kits, Media & Sera
  • Beads
    • Magnetic Beads
    • Fluroscent Beads
  • Disposables
• Instruments
  • Centrifuges
  • Cell Sorters
  • Magnetic-activated Cell Seperator Systems
  • Filtration Systems

By Cell Type

• Human Cells
  • Differntiated Cells
  • Stem Cells
• Animal Cells

By Cell Source

• Bone Marrow
• Adipose Tissues
• Cord Blood/ Embryonic Stem Cells
• Other Cell Sources

By Technique

• Centrifugation-based Cell Isolation
• Surface Marker-based Cell Isolation
• Filtration-based Cell Isolation
• Cell Isolation Market, by Application
• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• Tissue Regeneration & Regenerative Medicine
• In-vitro Diagnostics
• Other Applications

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Diagnostic Laboratories
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments

• In October 2022, Thermo Fisher Scientific, Inc. launched DynaCellect, a next-generation cell isolation, cell activation, cell depletion instrument. It also launched the Dynabeads magnetic beads removal instrument to optimize the cell therapy manufacturing process.
• In June 2022, Terumo BCT and GenCure collaborated to advance cell and gene therapy manufacturing solutions.
• In May 2022, Terumo BCT inaugurated its second manufacturing facility in Colorado.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst